Global EditionASIA 中文雙語Fran?ais
    China
    Home / China / Health

    TCM soup can help cut COVID-19 death rate of patients in half, study shows

    By WANG XIAOYU | CHINA DAILY | Updated: 2021-05-10 09:21
    Share
    Share - WeChat
    Pharmacists dispense medicines according to Qingfei Paidu Soup prescriptions at Anhui University of Chinese Medicine on Feb 21, 2020. [Photo/Xinhua]

    Qingfei paidu soup, a widely used traditional Chinese medicine to treat COVID-19 infections, can help reduce the rate of death among hospitalized patients by half, a recent study has shown.

    The study examines more than 8,900 COVID-19 cases that received treatment at 15 hospitals in Hubei province-the hardest-hit region during the epidemic-from January to May last year, with nearly 30 percent of them having taken qingfei paidu as part of their therapies.

    Results suggest that the mortality rate for those undergoing the TCM treatment stands at 1.2 percent, while the rate for other patients is 4.8 percent.

    The study, led by researchers from Fuwai Hospital of the Chinese Academy of Medical Sciences & Peking Union Medical College, concluded that the use of qingfei paidu is associated with a 50 percent reduction of mortality in hospitalized COVID-19 patients, without amplifying the risk of developing acute liver or kidney injuries.

    It was first published on preprint website MedRxiv.org in late December. On March 31, it was released on Phytomedicine, a peer-reviewed journal.

    Li Jing, head of the research team, said based on the national diagnosis and treatment guideline for COVID-19 diseases, qingfei paidu is the only prescription that is recommended for treating all patients ranging from mild to critical cases.

    "The extensive delivery of TCM medication in hospitalized patients during the outbreak had created a sound base for our research because when appraising clinical effectiveness of a certain drug, it is crucial to start by collecting and analyzing from a large enough number of cases," she said.

    Qingfei paidu is a concoction that includes dozens of TCM herbs and roots, including ephedra, licorice root and bitter almond. The initial version of the prescription is believed to have originated during the Eastern Han Dynasty (25-220).

    Zhang Boli, president of the Tianjin University of Traditional Chinese Medicine, said during an earlier interview that preliminary studies show the therapy mainly works on lungs while offering protection for some other organs against the virus. It can also stem the virus's replication, Zhang said.

    According to the National Administration of Traditional Chinese Medicine, previous studies have already attested to the herbal prescription's efficacy in preventing mild and moderate cases from worsening into severe infections, but evidence of its role in lowering the death rate was lacking.

    "The study is by far the largest clinical research on qingfei paidu and its findings have provided potent evidence for proving its marked efficacy in saving the lives of COVID-19 patients," the administration said.

    As of now, there is no approved specific treatment for COVID-19 patients. During the fight against the epidemic, 92 percent of confirmed patients had undergone TCM therapies, with the efficacy rate in Hubei reaching 90 percent, according to a white paper released in June.

    Li said the new study is retrospective and based on real-world cases.

    "If a randomized, double-blind, placebo-controlled clinical study can be conducted in the future, the TCM drug's clinical efficacy can be further verified, and its global application is expected to expand," she added.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
     
    亚洲爆乳无码一区二区三区| 一区二区中文字幕| 炫硕日本一区二区三区综合区在线中文字幕 | 国色天香中文字幕在线视频| 无码内射中文字幕岛国片| 一二三四在线播放免费观看中文版视频| 亚洲精品无码不卡| 亚洲V无码一区二区三区四区观看 亚洲爆乳精品无码一区二区三区 亚洲爆乳无码一区二区三区 | 亚洲一区AV无码少妇电影☆| 久久精品aⅴ无码中文字字幕不卡 久久精品aⅴ无码中文字字幕重口 | 国产成人午夜无码电影在线观看| 亚洲美日韩Av中文字幕无码久久久妻妇 | 中文字幕人成人乱码亚洲电影| 久久亚洲AV成人无码国产| 中文字幕亚洲一区| 亚洲福利中文字幕在线网址| 亚洲国产精彩中文乱码AV| 一本之道高清无码视频| 极品粉嫩嫩模大尺度无码视频| 小13箩利洗澡无码视频网站| 精品多人p群无码| 中文字幕精品视频在线| 精品久久久久久久久久中文字幕 | 久久久久久久久久久久中文字幕 | 国产精品无码久久综合网| 精品少妇无码AV无码专区| 日韩精品无码一区二区中文字幕 | 亚洲精品无码午夜福利中文字幕| 东京热av人妻无码专区| 日本无码小泬粉嫩精品图| 欧美日韩不卡一区二区三区中文字| 色综合久久中文综合网| 日本中文字幕网站| 日本中文字幕免费看| 中文字幕精品无码一区二区| 日日摸夜夜添无码AVA片| 成人无码a级毛片免费| 无码专区久久综合久中文字幕| 无码精品一区二区三区在线 | 人妻丰满AV无码久久不卡| 日韩人妻无码精品久久免费一|